Multiple autoimmune events after autologous bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 7, 1997, Pages 745-747

  Lambertenghi Deliliers, G ^a   Annaloro, C ^a   Della Volpe, A ^a   Oriani, A ^a   Pozzoli, E ^a   Soligo, D ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

AutoBMT; Autoimmune diseases; Graft versus host disease; Myelodysplastic syndrome

Indexed keywords

ERYTHROCYTE ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; COMPLICATION; FEMALE; GRAFT VERSUS HOST REACTION; HASHIMOTO DISEASE; HUMAN; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; PRIORITY JOURNAL; RASH; THROMBOCYTOPENIC PURPURA;

EID: 0030969813     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700711     Document Type: Article

References (12)

1. Esteban JM, Somlo G. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. Mod Pathol 1995; 8: 59-64.
2. Carlson K, Lonnerholm G, Smedmyr B et al. Thyroid function after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10: 123-127.
3. Sivakumaran M, Hutchinson RM, Pringle H et al. Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 1995; 15: 531-536.
4. Sanmarco M, Vialettes B, Maraninchi D, Bernard D. Autoantibody formation after bone marrow transplantation: a comparison between autologous and allogeneic grafts. Autoimmunity 1991; 11: 7-12.
5. Hess AD, Jones RC, Santos GW. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect. Bone Marrow Transplant 1993; 12 (Suppl. 3): S65-S69.
6. Kennedy MJ, Vogelsang GB, Beveridge RA et al. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1993; 11: 478-484.
7. Tiwari JL, Terasaki PI (eds). I. Myasthenia gravis. II. Graves' disease. HLA and Disease Associations. Springer-Verlag: New York. 1985, pp 167-173, 214-220.
8. Rainey M, Harrison P, Hows JM et al. Spontaneous graftversus-host disease following autologous peripheral blood progenitor cell transplantation in chronic myelogenous leukaemia. Bone Marrow Transplant 1996; 17: 1077-1079.
9. Wolin MJ, Rigor RL. Acute graft-versus-host disease in a recipient of a twin blood cell transplant. Bone Marrow Transplant 1996; 17: 125-126.
10. Greeno EW, Haake R, McGlave P et al. Lupus inhibitors following bone marrow transplant. Bone Marrow Transplant 1995; 15: 287-291.
11. Ratanatharathorn V, Uberti J, Karanes C et al. Phase I study of alpha-interferon augmentation of cyclosporine-induced graftversus-host disease in recipients of autologous bone marrow transplantation. Bone Marrow Transplant 1994; 13: 625-630.
12. Lambertenghi-Deliliers G. Orazi A, Luksch R et al. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol 1991; 78: 161-166.